3 protocol(s) meet the specified criteria
PI: Foster, Matthew
Protocol No.TitleStatus
CP-MGD006-01A Phase 1, First-in-Human, Dose Escalation Study of MGD006, a CD123 x CD3 Dual Affinity Re-Targeting (DART) Bi-Specific Antibody-Based Molecule, in Patients with Relapsed or Refractory Acute Myeloid Leukemia Open
LCCC1111An Open-Label Dose-Finding Study of Lenalidomide as Re-Induction/Consolidation Followed by Lenalidomide Maintenance Therapy for Adults >/= 60 Years of Age with AML in Partial or Complete Response Following Conventional Induction TherapyOpen
LCCC1541-ATLAdministration of autologous CAR-T cells targeting the CD19 antigen and containing the inducible caspase9 safety switch in patients with relapsed/refractory Acute Lymphoblastic Leukemia Open